Acknowledgements
This study was supported by FISM (Federazione Italiana per lo Studio delle Sindromi Mielodisplastiche). This work was supported by a special grant from “AIRC 5 per mille” to the AGIMM group (AIRC-Gruppo Italiano Malattie Mieloproliferative); for a complete list of AGIMM investigators see at http://www.progettoagimm.it. The study was partially funded by grants from: MURST-COFIN, AIL (Associazione Italiana contro le Leucemie), and by Regione Piemonte.
Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1312385.